Lupin’s wholly owned subsidiary -- Lupin Manufacturing Solutions (LMS) has received the good manufacturing practice (GMP) certification from the Therapeutic Goods Administration (TGA), Australia’s medicines and medical devices regulator for its API manufacturing facility in Dabhasa, Gujarat. LMS offers pharmaceutical CDMO services and is engaged in the manufacturing and supply of APIs.
Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.
